Abstract
Stroke is one of the leading causes of morbidity and mortality all over the world. Stroke can be ischemic or hemorrhagic. The mainstay of treatment of ischemic stroke is the intravenous administration of rt-PA. Patients who receive intravenous rt-PA are more likely to resume independent activities of daily living after treatment. However, not all patients are good candidates for this treatment. We discuss in this brief review other treatment modalities including intra-arterial thrombolysis, and intracranial angioplasty and stenting. We also address the current indications for treatment of ruptured cerebral aneurysms in patients with subarachnoid hemorrhage
References
American Heart Association. 1998 Heart and stroke statistical update. Dallas: American Heart Association, 1997
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587
Ueda T, Sakaki S, Yuh WT, Nochide I, Ohta S. Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography. J Cereb Blood Flow Metab 1999; 19:99-108
Ueda T, Sakaki S, Kumon Y, Ohta S. Multivariate analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999; 30:2360-2365
Suarez JI, Sunshine JL, Tarr R, et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999; 30:2094-2100
Gonner F, Remonda L, Mattle H, et al. Local intra- arterial thrombolysis in acute ischemic stroke. Stroke 1998;29:1894-1900
del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thrombolembolism. Stroke 1998;29:4-1
Edwards MT, Murphy MM, Geraghty JJ, Wulff JA, Konzen JP. Intra-arterial cerebral thrombolysis for acute ischemic stroke in a community hospital. AJNR 1999;20:1682-1687
Jahan R, Duckwiler GR, Kidwell CS, et al. Intraarterial thrombolysis for treatment of acute stroke: experience in 26 patients with long-term follow-up. AJNR 1999;20:1291-1299
Ueda T, Hatakeyama T, Kohno K, Kumon Y, Sasaki S Endovascular treatment for acute thrombotic occlusion of the middle cerebral artery: local intra-arterial thrombolysis combined with percutaneous transluminal angioplasty. Neuroradiology 1997;39:99-104
Casto L, Caverni L, Camerlingo M, et al. Intra-arterial thrombolysis in acute ischemic stroke: experience with a superselective catheter embedded in the clot. J Neurol Neurosurg Psychiatry 1996; 60:667-670
Barnwell SL, Clark WM, Nguyen TT, O’Neil OR, Wynn ML, Coull BM. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR 1994; 15:1817-1822
Barr JD, Mathis JM, Wildenhain SL, Wechsler L, Jungreis CA, Horton JA. Acute stroke intervention with intraarterial urokinase infusion. J Vasc Interv Radiol 1994; 5:705-713
Casto L, Moschini L, Camerlingo M, et al. Local intraaterial thrombolysis for acute stroke in the carotid artery territories. Acta Neurol Scand 1992; 86:308-311
Higashida RT, Halbach VV, Branwell SL, Dowd CF, Hieshima GB. Thrombolytic therapy in acute stroke. J Endovasc Surg 1994; 1:4-15
Sasaki O, Takeuchi S, Koike T, Koizumi T, Tanaka R. Fibrinolytic therapy for acute embolic stroke: intravenous, intracarotid, and intra-arterial local approaches. Neurosurgery 1995; 36:246-252
Mori E, Tabuchi M, Yoshida T, Yamadori A. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 1988; 19:802-812
Theron J, Courtheoux P, Casasco A, et al. Local intraarterial fibrinolysis in the carotid territory. AJNR 1989; 10:753-765
Zeumer H, Freitag HJ, Zanella F, Thie A, Arning C. Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA). Neuroradiology 1993; 35:159-162
Phan TG, Wijdicks EFM. Intra-arterial thrombolysis for vertebrobasilar circulation ischemia. Crit Care Clin 1999; 15: 719-742
Matsumoto K, Satoh K. Topical intra-arterial urokinase infusion for acute stroke. In Hacke W, del Zoppo GJ, Hirschberg M (eds). Thrombolytic therapy in acute ischemic stroke. New York, NY, Springer Publishing Co., Inc., 1991, pp 207-212
Becker KJ, Purcell LL, Hacke W, Hanley DF. Vertebrobasilar thrombosis: diagnosis, management, and the use of intra-arterial thrombolytics. Crit Care Med 1996; 24:1729-1742
Cross DT 3rd, Moran CJ, Akins PT, Angtuaco EE, Diringer MN. Relationship between clot location and outcome after basilar artery thrombolysis. AJNR 1997; 18: 1221-1228
Cross DT 3rd, Moran CJ, Akins PT, Angtuaco EE, Derdeyn CP, Diringer MN. Collateral circulation and outcome after basilar artery thrombolysis. AJNR 1998; 19:1557-1563
Wijdicks EF, Nichols DA, Thielen KR, et al. Intra-arterial thrombolysis in acute basilar artery thromboembolism: the initial Mayo Clinic experience. Mayo Clin Proc 1997; 72:1005-1013
Brandt T, von Kummer R, Muller-Kuppers M, Hacke W. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 1996; 27:875-881
Becker KJ, Monsein LH, Ulatowski J, Mirski M, Williams M, Hanley DF. Intraarterial thrombolysis in vertebrobasilar occlusion. AJNR 1996; 17:255-262
Zeumer H, Hacke W, Ringelstein EB. Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease. AJNR 1983; 4:401-404
Hacke W, Zeumer H, Ferbert A, Bruckmann H, del Zoppo GJ. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988; 19:126-1222
Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial. JAMA 1999; 282:2003-2011
Lewandowski C, Frankel M, Tomsick T, et al. Combined intravenous and intra-arterial r-tPA versus intraarterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999; 30:2598-2605
Ernst R, Pancioli A, Tomsick T, et al. Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke. Stroke 2000; 31:2552-2557
Suarez JI, Zaidat OO, Sunshine JL, et al. Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes. Neurosurgery 2002;50:251-259
The IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: The Interventional Management of Stroke Study. Stroke 2004;35:904-911
Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race- ethnicity and determinants of intracranial atherosclerotic cerebral infarction. Stroke 1995;26:14-20
Thijs VN, Albers GW . Symptomatic intracranial atherosclerosis. Outcome of patients who fail antithrombotic therapy. Neurology 2000;55:490-497
Mazighi M, Tanasescu R, Ducrocq X, Vicaut E, Bracard S, Hodart E, Woimant F. Prospective study of symptomatic atherothrombotic intracranial stenoses: The GESICA study. Neurology 2006;66:1187-1191
Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chatuverdi S, Kasner SE, Bebesch CG, Sila CA, Jovin TG, Romano JG. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305-16.
The SSYLVIA Study Investigators (2004). Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA). Stroke 35:1388-1392
Guglielmi G, Vinuela F. Intracranial aneurysms. Guglielmi electrothrombotic coils. Neurosurg Clin N Am 1994;5(3):427-435
International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial. Lancet 2003;360:1267-74
Molyneux AJ, Kerr RSC, Yu LM, Sneade M, Yarnold JA, Sandercock P. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptures intracranial aneurysms: a randomized comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 2005;366:809-17
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.